Large, Long-Term Study Shows Avandia Has No Increased Overall Cardiovascular Risk Compared to Other Commonly Used Diabetes Medicines Jun 6, 2009
Important safety information for Avandia(R) (rosiglitazone maleate). Prescription AVANDIA, along with diet and exercise, helps improve blood sugar control in adults with type 2 diabetes. (PR Newswire)
FDA Asks GSK To Place Black Box Warning On Avandia Nov 19, 2007
Generic versions of Avandia, its scientific name is rosiglitazone maleate - are available under 10 different brand names in the Indian market and sold to around eight million people. GSK sells the drug under Windia brand name in India. (TopNews)
Glaxo updates prescribing information for Avandia in US Aug 16, 2007
This approval allows GSK to implement changes in the label for Avandia (rosiglitazone maleate) as previously committed ... The changes related to CHF are being implemented on the labels of all rosiglitazone-containing products: Avandia, Avandamet (rosiglitazone maleate and metformin hydrochloride) and Avandaryl (rosiglitazone maleate and glimepiride). (SpiritIndia)
FDA Advisory Panel Votes 22 to 1 for Avandia(R) to Remain Available to Patients in the US Jul 31, 2007
PHILADELPHIA, July 30 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today welcomed the nearly unanimous recommendation of an U.S. Food and Drug Administration's (FDA) advisory committee to support Avandia's (rosiglitazone maleate) continued availability to patients in the US. The company said it will continue to provide information to the FDA to assist in the Agency's final decision-making ... Important Safety Information for Avandia(R) (rosiglitazone maleate) Avandia, along with diet... (PR Newswire)
Avandia Stirs Debate at Diabetes Meeting Jun 28, 2007
CHICAGO (Reuters) - Controversy over the popular diabetes drug rosiglitazone maleate (Avandia; GlaxoSmithKline Plc) took center stage on Monday at a meeting of the world's experts on the disease, where researchers debated findings that the drug could boost heart attack risk. The drug has been under a cloud since an analysis published in The New England Journal of Medicine last month found that Avandia increased the risk of heart attack by 43 percent, along with the risk of death from heart... (MEDLINEplus)
New Data Show Patients Treated With Avandia(R) (Rosiglitazone Maleate) Incurred Lower Medical Costs and Used Fewer Healthcare Resources When Compared to Patients Treated With Sulphonylureas Jun 25, 2007
CHICAGO, June 24 /PRNewswire-FirstCall/ -- New findings from a retrospective cohort study using real-world claims data of more than 15,000 drug naive patients with type 2 diabetes showed that initial therapy with Avandia(R) (rosiglitazone maleate) was associated with significantly fewer healthcare visits and lower total medical costs when compared to patients initiating therapy with a sulfonylurea ... Important Safety Information for Avandia(R) (rosiglitazone maleate) Avandia, along with diet... (PR Newswire)
